Computational approaches for drug design at the protein-protein interface
The ability to design drugs that disrupt formation of protein-protein interfaces is of particular interest to the pharmaceutical industry due to its promise for opening an entire new range of drug targets, many of which have already been well characterised in terms of their disease causing effect on...
Main Author: | |
---|---|
Other Authors: | |
Published: |
University of Leeds
2010
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.536113 |